Delivery Order SPE2DB24D2013-SPE2DB25FCKDX
- Not listed
- The Defense Logistics Agency awarded a $15,411.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pen 3ml formulations. The contract was competitively awarded without a set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the company's broader Indefinite Delivery...
- The Defense Logistics Agency awarded a $53,875.27 delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3ml vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,497.95 delivery order to AmerisourceBergen Drug Corp for Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $29,120.01 delivery order to AmerisourceBergen Drug Corp for Ozempic (semaglutide) 1 mg/dose in 3 mL vials. The contract, awarded on August 18, 2025, with completion targeted for August 19, 2025, utilizes firm fixed-price pricing with no set-aside designation, indicating competitive award based on capability. Performance will be executed from AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $11,073.16 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL vials, with an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $2,621.17 to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3ml quantities. This competitively awarded, firm fixed-price delivery order is set to be completed by August 29, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a $7,651.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Ozempic (semaglutide) 0.25–0.5 mg/dose pens in 3 mL vials. This is a non-set-aside contract with performance at the vendor's Conshohocken, Pennsylvania facility and an ultimate completion date of September 4, 2025. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $1,694.87 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Ozempic (semaglutide) 1 mg/dose injectable medication in 3 ml vials. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, scheduled for completion by September 10, 2025. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $17,428.58 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pens in 3mL formulation. This competitively awarded, firm fixed-price contract will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of August 21, 2025. The delivery order is classified as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $41,046.84 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials. This contract is a firm fixed-price delivery order with no set-aside designation, competitively awarded and scheduled for completion by July 28, 2025. AmerisourceBergen will perform the work at its corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger Indefinite Delivery...
- SPE2DB24D2013Indefinite Delivery Contract
- SPE2DB24D2013-SPE2DB25FCKDXDelivery Order
The Defense Logistics Agency awarded a $52,402.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 1 mg/dose in 3 mL vials, with a completion date of September 15, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, functions as a critical vendor for federal medical procurement across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's contract portfolio with DLA demonstrates extensive capability in supplying brand-name and generic medications, vaccines, medical devices, and specialized pharmaceuticals across multiple therapeutic domains. This specific delivery order supports the military's pharmaceutical supply chain and represents typical transactions under the broader IDC arrangement, which enables flexible procurement of medical commodities needed to sustain military healthcare operations worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $52.4k | 9/12/25 |